Health ministers in the European Union (EU) met May 9 in Malta with top executives and heads of pharmaceutical companies on ways to tackle the ongoing surge in medical costs.
Health ministers in June last year initiated discussions to address the problem, citing market failures having been responsible for preventing crucial drugs from reaching patients.
The system through which treatment is priced “may not always promote the best possible outcome for patients on society,” health officials said.
At the June meeting, other member states were urged to develop a strategy for initiating price negotiations with the pharmaceutical industry.
“We would like to see more transparency in the way the pharmaceutical companies negotiate with the purchasing authority,” Chris Fearne, Malta’s health minister, said in an interview with EURACTIV.com.
(Source: Sarantis Michalopoulos, www.EURACTIV.com, May 9, 2017)